SYNC

Syncona (SYNC)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:SYNC
DataOraFonteTitoloSimboloCompagnia
03/05/202408:00RNS Regulatory NewsSyncona Limited Transaction in Own SharesLSE:SYNCSyncona Limited
01/05/202415:14RNS Regulatory NewsSyncona Limited Total Voting RightsLSE:SYNCSyncona Limited
11/04/202415:22Alliance NewsAlliance NewsSyncona agrees to sell stake in investee company for GBP7.4 millionLSE:SYNCSyncona Limited
11/04/202413:02RNS Regulatory NewsSyncona Limited Century Therapeutics to acquire Clade TherapeuticsLSE:SYNCSyncona Limited
04/04/202418:06Alliance NewsAlliance NewsIN BRIEF: Syncona notes investee Achilles's annual loss narrowsLSE:SYNCSyncona Limited
04/04/202412:50RNS Regulatory NewsSyncona Limited Achilles reports full year 2023 Financial ResultsLSE:SYNCSyncona Limited
04/04/202412:47RNS Regulatory NewsSyncona Limited Achilles provides clinical data updateLSE:SYNCSyncona Limited
14/03/202415:16Alliance NewsAlliance NewsSyncona portfolio company Autolus posts widened loss for 2023LSE:SYNCSyncona Limited
14/03/202412:05RNS Regulatory NewsSyncona Limited Autolus reports full year 2023 Financial ResultsLSE:SYNCSyncona Limited
06/03/202418:22RNS Regulatory NewsSyncona Limited Director DeclarationLSE:SYNCSyncona Limited
20/02/202413:02RNS Regulatory NewsSyncona Limited Acquisition of Freeline Becomes EffectiveLSE:SYNCSyncona Limited
12/02/202419:01Alliance NewsAlliance NewsIN BRIEF: Freeline shareholders approve Syncona acquisitionLSE:SYNCSyncona Limited
12/02/202417:45RNS Regulatory NewsSyncona Limited Freeline Shareholders Approve AcquisitionLSE:SYNCSyncona Limited
08/02/202414:45Alliance NewsAlliance NewsUPDATE: Syncona portfolio strengthens thanks to AutolusLSE:SYNCSyncona Limited
08/02/202413:53RNS Regulatory NewsSyncona Limited Autolus offering (Amendment)LSE:SYNCSyncona Limited
08/02/202413:13RNS Regulatory NewsSyncona Limited Autolus announces pricing of public offeringLSE:SYNCSyncona Limited
08/02/202413:05RNS Regulatory NewsSyncona Limited Beacon presents 12-month clinical dataLSE:SYNCSyncona Limited
08/02/202411:50RNS Regulatory NewsSyncona Limited Autolus announces Strategic CollaborationLSE:SYNCSyncona Limited
08/02/202410:41Alliance NewsAlliance NewsSyncona portfolio strengthens in third quarter thanks to AutolusLSE:SYNCSyncona Limited
08/02/202408:00RNS Regulatory NewsSyncona Limited Third Quarter UpdateLSE:SYNCSyncona Limited
22/01/202413:19Alliance NewsAlliance NewsIN BRIEF: Syncona notes FDA acceptance of Autolus's BLA for obe-celLSE:SYNCSyncona Limited
22/01/202413:05UK RegulatorySyncona Limited Autolus announces acceptance of BLA for obe-celLSE:SYNCSyncona Limited
19/01/202409:36Alliance NewsAlliance NewsSyncona says Freeline trial for Gaucher disease treatment positiveLSE:SYNCSyncona Limited
19/01/202408:00UK RegulatorySyncona Limited Freeline announces further dataLSE:SYNCSyncona Limited
11/12/202308:00UK RegulatorySyncona Limited Autolus presents clinical data updatesLSE:SYNCSyncona Limited
04/12/202310:37Alliance NewsAlliance NewsIN BRIEF: Syncona notes Beacon's "encouraging" AGTC-501 trial dataLSE:SYNCSyncona Limited
04/12/202308:00UK RegulatorySyncona Limited Beacon presents data from AGTC-501 in XLRPLSE:SYNCSyncona Limited
27/11/202320:03Alliance NewsAlliance NewsTRADING UPDATES: Molten Ventures completes raise; Saietta proposes oneLSE:SYNCSyncona Limited
27/11/202313:05UK RegulatorySyncona Limited Autolus submits key regulatory filing for obe-celLSE:SYNCSyncona Limited
22/11/202315:30Alliance NewsAlliance NewsIN BRIEF: Syncona agrees to buyout deal with Freeline TherapeuticsLSE:SYNCSyncona Limited
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:SYNC
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network